Human IL-15

Recombinant human IL-15 (interleukin 15) promotes proliferation of activated T, NK, and B cells . The regulatory cytokine IL-15 has important diverse roles in the immune system. It is structurally related to IL-2 and they share many functional characteristics. The recombinant protein is optimized for use in cell culture, differentiation studies, and functional assays.

Select a quality grade:
Select a size:
Other sizes

Related products for Human IL-15

Specifications for Human IL-15
Overview

Recombinant human IL-15 (interleukin 15) promotes proliferation of activated T, NK, and B cells . The regulatory cytokine IL-15 has important diverse roles in the immune system. It is structurally related to IL-2 and they share many functional characteristics. The recombinant protein is optimized for use in cell culture, differentiation studies, and functional assays.

Applications

Human IL-15 can be used for a variety of applications, including:

  • Activation and expansion of NK and NKT cells.
  • In vitro differentiation of NK cells, e.g., from purified CD34+ cells.
  • In vitro T cell expansion, e.g., of naive CD8+ T cells, and T cell activation, e.g., of CTLs.
Detailed product information

Biological activity

Determination method
Proliferation of CTLL-2 cells (NIBSC 95/554)
Research grade
≥ 2×106 U/mg
Premium grade
≥ 5×106 U/mg (Typical activity 1.1×107 U/mg)
We measure the biological activity of each batch of MACS Premium-Grade Cytokines and state the results in the Certificate of Analysis (CoA). Based on the lot-specific activity, exact doses of active cytokine can be applied to cell culture experiments. This allows for reproducible cell culture conditions without the need for time-consuming lot-to-lot testing.
Background information

IL-15 is a member of the four α-helix bundle cytokine family. It is produced by different cell types, including epithelial cells, monocytes, muscle and placenta cells. IL-15 is a potent lymphoid cell growth factor. It stimulates the proliferation of activated T cells and promotes the generation of cytotoxic T lymphocytes (CTLs). IL-15 also induces the generation, proliferation, and activation of NK cells as well as B cell growth and immunoglobulin production. In addition, IL-15 is important for the maintenance of CD8+ memory T cells. For binding and signaling IL-15 uses the unique IL-15 receptor α-chain, but shares the β- and γ-chain of the IL-2 receptor.

Quality description

Research-grade cytokines are suitable for a wide variety of cell culture applications. They are sterile-filtered prior to lyophilization. Generally, endotoxin levels are <0.1 ng/μg (<1 EU/μg), and purities are >95%. The biological activity is tested in appropriate bioassays.

Premium-grade cytokines offer the convenience of high and well-defined biological activities and allow exact unit dosing for demanding applications. The biological activity is determined after lyophilization and reconstitution, and normalized to WHO/NIBSC standards whenever available. In general, endotoxin levels are <0.01 ng/μg (<0.1 EU/μg), and purities are >97%. Lot-specific activities are stated in the Certificate of Analysis (www. miltenyibiotec.com/certificates).

Product data and images for Human IL-15
Figure 1

Human IL-15 activity assay. The biological activity of Human IL-15 is determined by proliferation assay using CTLL2 cells.

Figure 2

SDS-PAGE of Human IL-15, premium grade under reducing (R) and non-reducing (NR) conditions.

Figure 3

Mass spectrometry analysis (ESI-MS) of Human IL-15, premium grade. The peak corresponds to the calculated molecular mass of 12770 Da.

Resources for Human IL-15
Documents and Protocols
Certificates

To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.

Get certificate

Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.

Contact technical support

Citations for Human IL-15
Publications
  1. Hoerster, K. et al. (2021) HLA Class I Knockout Converts Allogeneic Primary NK Cells Into Suitable Effectors for "Off-the-Shelf" Immunotherapy. Front Immunol 11: 586168
  2. Alzubi, J. et al. (2020) PSMA-Directed CAR T Cells Combined with Low-Dose Docetaxel Treatment Induce Tumor Regression in a Prostate Cancer Xenograft Model. Mol. Ther. Oncolytics 18: 226-235
  3. Dietz, L. et al. (2010) Tracking human contact allergens: from mass spectrometric identification of peptide-bound reactive small chemicals to chemical-specific naive human T-cell priming. Toxicol. Sci. 117 (2): 336-347
  4. Arcangeli, S. et al. (2020) Next-Generation Manufacturing Protocols Enriching T SCM CAR T Cells Can Overcome Disease-Specific T Cell Defects in Cancer Patients. Front Immunol 11: 1217
  5. Olden, B. R. et al. (2019) Cell-Templated Silica Microparticles with Supported Lipid Bilayers as Artificial Antigen-Presenting Cells for T Cell Activation. Adv Healthc Mater 8 (2): e1801188
  6. Juelke, K. et al. (2010) CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells. Blood 116 (8): 1299-1307
  7. Formenti, S. C. et al. (2018) Radiotherapy Induces Responses of Lung Cancer to CTLA-4 Blockade. Nat Med 24 (12): 1845-1851
  8. Alzubi, J. et al. (2020) Automated generation of gene-edited CAR T cells at clinical scale. Mol Ther Methods Clin Dev 20: 379-388
  9. Nicolas-Boluda, A. et al. (2021) Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment. Elife 10: e58688
  10. Alvarez-Breckenridge, C. A. et al. (2012) The histone deacetylase inhibitor valproic acid lessens NK cell action against oncolytic virus-infected glioblastoma cells by inhibition of STAT5/T-BET signaling and generation of gamma interferon. J. Virol. 86 (8): 4566-4577
  11. Gordy, L. E. et al. (2011) IL-15 regulates homeostasis and terminal maturation of NKT cells. J Immunol 187 (12): 6335-6345
  12. Galletti, G. et al. (2020) Two subsets of stem-like CD8+ memory T cell progenitors with distinct fate commitments in humans. Nat Immunol 21 (12): 1552-1562
  13. Fuchs, S. et al. (2014) Patients with T+/low NK+ IL-2 receptor γ chain deficiency have differentially-impaired cytokine signaling resulting in severe combined immunodeficiency. Eur. J. Immunol. 44 (10): 3129-3140
  14. Rotolo, A. et al. (2018) Enhanced Anti-lymphoma Activity of CAR19-iNKT Cells Underpinned by Dual CD19 and CD1d Targeting. Cancer Cell 34 (4): 596-610
  15. Soman, G. et al. (2009) MTS dye based colorimetric CTLL-2 cell proliferation assay for product release and stability monitoring of interleukin-15: assay qualification, standardization and statistical analysis. J. Immunol. Methods 348: 83-94

You have previously chosen International as your location.
What do you want to do?